Synthesis and cytotoxic activity of 1-alkoxy- and 1-amino-2-hydroxy- 1,2-dihydroacronycine derivatives

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 5, 1999, Pages 611-614

  Magiatis, Prokopios ^a   Mitaku, Sofia ^a   Skaltsounis, Alexios Leandros ^a   Tillequin, François ^b   Koch, Michel ^b   Pierré, Alain ^c   Atassi, Ghanem ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Acridone; Acronycine; Alkaloid; Cytotoxicity

Indexed keywords

1 ALKYLOXY 2 HYDROXY 1,2 DIHYDROACRONYCINE DERIVATIVE; 1 AMINO 2 HYDROXY 1,2 DIHYDROACRONYCINE DERIVATIVE; 1 BENZYLOXY 2 HYDROXY 1,2 DIHYDROACRONYCINE; 2 ACETOXY 1 BENZYLOXY 1,2 DIHYDROACRONYCINE; 2 ACETOXY 1 HYDRAZINO 1,2 DIHYDROACRONYCINE; 2 ACETOXY 1 METHOXY 1,2 DIHYDROACRONYCINE; 2 ACETOXY 1 METHYLACETAMIDO 1,2 DIHYDROACRONYCINE; 2 ACETOXY 1 METHYLAMINO 1,2 DIHYDROACRONYCINE; 2 ACETOXYACRONYCINE; 2 CHLOROACETOXY 1 BENZYLOXY 1,2 DIHYDROACRONYCINE; 2 CHLOROACETOXY 1 METHOXY 1,2 DIHYDROACRONYCINE; 2 HYDROXY 1 METHOXY 1,2 DIHYDROACRONYCINE; 2 HYDROXY 1 METHYLAMINO 1,2 DIHYDROACRONYCINE; ACRONINE; UNCLASSIFIED DRUG;

AMINATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYST; CHEMICAL BOND; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG SYNTHESIS; ISOMERISM; LEUKEMIA L 1210; MOUSE; NONHUMAN; STEREOCHEMISTRY; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 0032994276     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.611     Document Type: Article

References (18)

1. Hughes G. K., Lahey F. N., Price J. R., Webb L. J., Nature (London), 62, 223-224 (1948).
2. Macdonald P. L., Robertson A. V., Aust. J. Chem., 19, 275-281 (1966).
3. Svoboda G. H., Lloydia, 29, 206-224 (1966).
4. Svoboda G. H., Poore G. A., Simpson P. J., Boder G. B., J. Pharm. Sci., 55, 758-768 (1966).
5. Dorr T. R., Liddil J. D., Von Hoff D. D., Soble M., Osborne C. K., Cancer Res., 49, 340-344 (1989).
6. Scarffe H. J., Beaumont A. R., Crowther D., Cancer Treatment Reports, 67, 93-94 (1983).
7. Schneider J., Evans E. L., Grunberg E., Fryer R. I., J. Med. Chem., 15, 266-270 (1972).
8. Shieh H. L., Pezzuto J. M., Cordell G. A., Chem.-Biol. Interact., 81, 35-55 (1992).
9. Elomri A., Michel S., Tillequin F., Koch M., Heterocycles, 34, 799-806 (1992).
10. Mitaku S., Skaltsounis A. L., Tillequin F., Koch M., Rolland Y., Pierre A., Atassi Gh., Pharm. Res., 13, 939-943 (1996).
11. Elomri A., Skaltsounis A. L., Michel S., Tillequin F., Koch M., Rolland Y., Pierre A., Atassi Gh., Chem. Pharm. Bull., 44, 2165-2168 (1996).
12. Brum-Bousquet M., Mitaku S., Skaltsounis A. L., Tillequin F., Koch M., Planta Med., 54, 470-471 (1988).
13. Elomri A., Mitaku S., Michel S., Skaltsounis A. L., Tillequin F., Koch M., Pierre A., Guilbaud N., Léonce S., Kraus-Berthier L., Rolland Y., Atassi Gh., J. Med. Chem., 39, 4762-4766 (1996).
14. Magiatis P., Mitaku S., Skaltsounis A. L., Tillequin F., Koch M., Pierré A., Atassi Gh., J. Nat. Prod., 61, 198-201 (1998).
15. Shnoder H. D., Bencze W., Halpern O., Schmid H., Chem. Ber., 92, 2338-2363 (1959).
16. Lemmich J., Lemmich E., Nielsen B. E., Acta Chem. Scand., 20, 2497-2507 (1966).
17. Pierré A., Dunn T. A., Kraus-Berthier L., Léonce S., Saint-Dizier D., Regnier G., Dhainaut A., Berlion M., Bizzari J. P., Atassi Gh., Invest. New Drug, 10, 137-148 (1992).
18. Léonce S., Perez V., Casabianca-Pignede M. R., Anstett M., Bisagni E., Pierré A., Atassi Gh., Invest. New Drug, 14, 169-180 (1996).